LeapZipBlog: Steve Blade's blog: Clinical Trial Management Systems Market Share, Company Profiles, and Insights Covering Market Share Forecast 2018 to 2028

Clinical Trial Management Systems Market Share, Company Profiles, and Insights Covering Market Share Forecast 2018 to 2028

August 12, 2019 by Steve Blade  

Fact.MR has recently developed a new research analysis on the clinical trial management system market, which exerts accurate forecasts on the market for the period between 2018 and 2027. This report is an explicit source of information, which imparts data on recent market dynamics, latest industry trends, potent markets, technology advancements & developments, and product innovation, along with an all-inclusive regional market coverage

Considering the slew of advantages clinical trial management systems have over traditional systems, the future belongs to web-based clinical trial management systems. The transition in the clinical trial management systems has been undergoing for some time now, and web-based procedures now account for a majority share of the market. However, it is also pertinent to mention that there is still a level of skepticism and reluctance in the clinical trial industry, especially in terms of data security and privacy. Availability of platforms and cloud-based products that utilize big data technology to optimize the cost of clinical development process can reduce some level of uncertainty.

According to the report, adoption of clinical trial management systems in Europe is concentrated in Germany, U.K., Spain, Italy, and France. These five markets collectively account for nearly 68% revenue share of the clinical trial management systems market. Germany is likely to retain its position as the most lucrative market for clinical trial management systems, whereas growth is likely to be sluggish in the U.K.

Request Free Sample Report Here:   

https://www.factmr.com/connectus/sample?flag=S&rep_id=832

Table of Content

Chapter 1 Executive Summary

Chapter 2 Global Clinical Trial Management Systems Market Overview
2.1 Introduction
2.2 Market Definition
2.3 Scope of the report

Chapter 3 Market Dynamics
3.1 Key Growth Drivers
      3.1.1 The Role of CTMS in Improving Workflow
      3.1.2 Importance in the eClinical Framework
      3.1.3 Growing Importance of CTMS in eClinical Value Chain
      3.1.4 Streamlining Research Activities
3.2 Key Market Restraints
      3.2.1 Evolving Roadblocks
      3.2.2 Complex Trial Management
3.3 Opportunities
      3.3.1 Progress in Web Technology
      3.3.2 Increasing Biomedical Research Funding
      3.3.3 Key Trends
      3.3.4 Increasing Outsourcing Activities
      3.3.5 Growing Focus on Price and Modularity
      3.3.6 List of Key CTMS Software
3.4 CTMS Process Chain
      3.4.1 Investment Feasibility Analysis for CTMS
3.5 Market White Space and Wheel of Fortune Analysis
3.6 Product Life Cycle Analysis
3.7 Porter’s Five Forces Analysis
3.8 PESTLE Analysis

Chapter 4 Global Clinical Trial Management Systems Market Analysis
4.1 Global Market Outlook
      4.1.1 Market Forecast and Analysis
      4.1.2 Regional Demand Assessment
              4.1.2.1 Market Share by Region
4.2 Global CTMS Market Analysis by Mode of Deployment
      4.2.1 Forecast by Mode of Deployment
      4.2.2 Y-o-Y Growth Comparison by Mode of Deployment
      4.2.3 Market Attractiveness Analysis by Mode of Deployment
4.3 Global CTMS Market Analysis by Component
      4.3.1 Forecast by Component
      4.3.2 Y-o-Y Growth Comparison by Component
      4.3.3 Market Attractiveness Analysis by Component
4.4 Global CTMS Market Analysis by Product Type
      4.4.1 Forecast by Product Type
      4.4.2 Y-o-Y Growth Comparison by Product Type
      4.4.3 Market Attractiveness Analysis by Product Type
4.5 Global CTMS Market Analysis by End-user
      4.5.1 Forecast by End-user
      4.5.2 Y-o-Y Growth Comparison by End-user
      4.5.3 Market Attractiveness Analysis by End-user

Chapter 5 North America Clinical Trial Management Systems Market Analysis
5.1 North America Market Outlook
      5.1.1 Market Forecast and Analysis
      5.1.2 Impact Assessment of Market Forces
      5.1.3 Country Wise Demand Assessment
              5.1.3.1 Market Value Share by Country
5.2 North America CTMS Market Analysis by Mode of Deployment
      5.2.1 Forecast by Mode of Deployment
      5.2.2 Y-o-Y Growth Comparison by Mode of Deployment
5.3 North America CTMS Market Analysis by Component
      5.3.1 Forecast by Component
      5.3.2 Y-o-Y Growth Comparison by Component
5.4 North America CTMS Market Analysis by Product Type
      5.4.1 Forecast by Product Type
      5.4.2 Y-o-Y Growth Comparison by Product Type
5.5 North America CTMS Market Analysis by End-User
      5.5.1 Forecast by End-User
      5.5.2 Y-o-Y Growth Comparison by End-User

To be Continue..............

Highlights

  • Clinical trial management systems market to surpass US$ 1 Bn during the review period
  • Incremental opportunity of US$ 116 Mn in web-based clinical trial management systems market
  • U.S. and EU5 among the most lucrative markets globally for vendors

Web-based clinical trial management systems continue to be the preferred mode of deployment for pharmaceutical and biotechnology companies, finds a new study by Fact.MR. The report projects that web-based clinical trial management systems will remain pervasive in the clinical trial management systems market during the review period 2018-2028, gaining an impressive US$ 116 Mn in incremental opportunity in a decade.

Future of Web-Based Clinical Trial Management Systems Market

Considering the slew of advantages clinical trial management systems have over traditional systems, the future belongs to web-based clinical trial management systems. The transition in the clinical trial management systems has been undergoing for some time now, and web-based procedures now account for a majority share of the market. However, it is also pertinent to mention that there is still a level of skepticism and reluctance in the clinical trial industry, especially in terms of data security and privacy. Availability of platforms and cloud-based products that utilize big data technology to optimize the cost of clinical development process can reduce some level of uncertainty.

Adoption of clinical trial management systems is mainly concentrated among pharmaceutical companies, contract research organizations (CROs), and healthcare providers. Pharmaceutical companies account for nearly three-fourth revenue share of the clinical trial management systems market, with healthcare providers accounting for a miniscule revenue share.

The penetration rate of clinical trial management systems is higher in the US and EU5, with pharmaceutical companies and other end-users adopting a proactive approach towards adoption of advanced software and services. The proliferation of clinical trial management systems in the US is reflected by the statistic that the country accounts for nearly 40% revenue share of the global clinical trial management systems market. The adoption rate is also impressive in Canada, albeit the market is likely to grow from a small base.

Have Any Query?? Ask Our Industry Expert:   https://www.factmr.com/connectus/sample?flag=AE&rep_id=832

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com